N E W S B Y T E S
LVPEI takes a monumental leap in ocular pharmacological research
The L V Prasad Eye Institute ( LVPEI ) created yet another milestone with the inauguration of the ‘ Dr Chigurupati Nageswara Rao Ocular Pharmacology Research Centre ’ at its Kallam Anji Reddy Campus in Hyderabad , Telangana .
This ground-breaking initiative , generously supported by Granules India Ltd . Named in honor of the late Dr Chigurupati Nageswara Rao , Former Chairman of Granules India Ltd . and a famous surgeon from Guntur , Andhra Pradesh , this state-of-the-art centre is set to revolutionize the landscape of ocular pharmacological research in India . This dedicated facility will delve into the intricacies of ocular diseases , understand drug interactions with pathogens ( disease-causing microorganisms ), and pioneer personalized eye care treatments .
Indian Immunologicals rolls out India ’ s first indigenously developed Hepatitis A vaccine
Indian Immunologicals Ltd ( IIL ) a wholly owned subsidiary of National Dairy Development Board ( NDDB ) and a leading biopharmaceutical company in India , marks a historic moment in public health with the launch of India ’ s first indigenously developed Hepatitis A vaccine , Havisure . The vaccine represents a significant step forward in India ’ s fight against Hepatitis A and is poised to make a substantial contribution to public health .
The new vaccine , Havisure is the result of extensive research and development efforts by IIL ’ s dedicated team of scientists and researchers . This indigenously developed vaccine is poised to play a crucial role in preventing Hepatitis A , a highly contagious liver infection that poses a significant public health challenge . Hepatitis A is a viral infection primarily spread through the fecaloral route , meaning that it is transmitted through the ingestion of contaminated food or water .
10
BioVoiceNews | March / April 2024